Search Results 3491-3500 of 26216 for oral

  1. Head and neck cancers - Doctors and departments - Mayo Clinic

    Oral and Maxillofacial Surgery · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric and Adolescent Medicine · Pediatric Otolaryngology · Physical Medicine ...

  2. Hematology - Clinical trials

    ... orally twice daily (BID), or critozinib, 250 mg orally BID. Patients ... Patients randomized to GDC-0199+R will be given GDC-0199 daily (oral, target ...

  3. Hematology - Clinical trials

    ... orally twice daily (BID), or critozinib, 250 mg orally BID. Patients ... Patients randomized to GDC-0199+R will be given GDC-0199 daily (oral, target ...

  4. Publications - Steven Attia, D.O. - Mayo Clinic

    Multicenter, open-label phase II study of daily oral regorafenib for chemotherapy-refractory, metastatic and locally advanced angiosarcoma. Ann Oncol. 2018 ...

  5. Ryan J. Solinsky, M.D. - Doctors and Medical Staff - Mayo Clinic

    Best Oral Presentation AwardInternational Autonomic Symposium, Vancouver, BC, CAN. 2017. Post-doctoral Fellow- Best Research AwardKessler Institute for ...

  6. Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection - Mayo Clinic

    difficile infection (CDI) after a primary episode and have completed at least two rounds of standard-of-care oral antibiotic therapy or have had at least ...

  7. Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection - Mayo Clinic

    difficile infection (CDI) after a primary episode and have completed at least two rounds of standard-of-care oral antibiotic therapy or have had at least ...

  8. Publications - John V. Murray, Jr., M.D. - Mayo Clinic

    Oral Maxillofac Surg Clin North Am. 2023 Aug; 35 (3):451-468 Epub 2023 Apr 07. View PubMed; Beegle RD, Murray JV Jr, Sandhu SJS. Normal and Variant Sinonasal ...

  9. A Study to Evaluate the Safety and Tolerability of Rebiotix RBX2660 (microbiota suspension) in Subjects with Recurrent Clostridium difficile Infection - Mayo Clinic

    ... oral antibiotic therapy; or; has had at least two episodes of severe CDI resulting in hospitalization. A positive stool test for the presence of toxigenic C ...

  10. Publications - Matthew P. Abdel, M.D. - Mayo Clinic

    Nonsteroidal Anti-Inflammatory Drugs and Oral Corticosteroids Mitigated the Risk of Arthrofibrosis After Total Knee Arthroplasty. J Arthroplasty. 2023 Jun ...